Skip to Main Content

The Journal of Neurosurgery (JNS) Publishes the First Article with Data from NPA’s Stereotactic Radiosurgery (SRS) Registry

Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry

The AANS, with support from Brainlab, has developed the national prospective Stereotactic Radiosurgery (SRS) registry. SRS is a minimally invasive approach using imaging guidance and stereotactic principles to deliver radiation to targeted cells within the body. The SRS registry captures treatment information for thousands of patients affected by brain metastases, benign brain tumors and arteriovenous malformations (AVMs).

Launched in 2015, the SRS registry is comprised of over 20 national, high-volume sites that collect patient-reported outcomes at routine intervals. The registry aims to define national patterns of care in radiosurgery with an eye to improving health care outcomes, supporting informed decision making and potentially lowering the cost of care. The NeuroPoint Alliance (NPA) oversees registry management and Brainlab provides the registry’s technology platform with a focus on increased efficiency of data collection, organization and enhanced analytics. The registry’s steering committee is helmed by NPA Board member Jason Sheehan, MD, PhD, FAANS, and the registry has enrolled over 3,000 patients to date.

February 2019